RNA vaccines, which have proved effective against COVID-19, are now being developed for many other diseases, including cancer ...

RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles ...

Genetic markers in the blood that can signal lung cancer risk up to 10 years before a person is diagnosed have been ...

Aptadir Therapeutics has raised €40 million in seed funding to advance its RNA inhibitor-based therapeutics platform, with CE ...

Uncover the latest and most impactful research in RNA Structure Prediction and Analysis. Explore pioneering discoveries, insightful ideas and new methods from leading researchers in the field. Much of ...

With the development of Spatial Transcriptomics, we have become able to see "which genes are expressed where" within a tissue ...

Hummingbird Diagnostics will present blood-based RNA biomarker data on prognosis and potential MRD assessment in stage III lung cancer at ESMO 2026.

GLP-1 drugs have revolutionized obesity treatment, but they can lead people to lose muscle mass along with fat. And when ...

Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer TherapeuticsOversubscribed round led by 4BIO Capital includes ...

Blueprint of Planetary Intelligence] Vol. 35 The Dawn of the RNA World: The Dual Drive of Catalysis and ...

Canada’s LNP expertise, public funding, evolving regulations and oncology pipeline unlock licensing, partnership and commercialization opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- "Canada RNA ...

Cross-kingdom RNA interference (RNAi) is a key virulence mechanism in which pathogens deliver small RNAs (sRNAs) into host plants, hijacking host ARGONAUTE (AGO) proteins to silence immunity-related ...